The FDA has approved the Tecnis Symfony IOL for the treatment of cataracts, Abbott announced in a press release. The approval includes the Tecnis Symfony Toric IOL for people with astigmatism.

ABBOTT PARK, Ill., June 24, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Marking (Conformite Europeenne) in Europe for the TECNIS ® Symfony Extended Range of Vision ...

Beverly Crawley had a lot of problems with her vision. She had lost a lot of her focusing ability with age and from astigmatism (a misshapen cornea). She also had cataracts, a condition in which the ...

Abbott announced that the Food and Drug Administration (FDA) has approved the Tecnis Symfony Intraocular Lenses for the treatment of cataracts. Abbott announced that the Food and Drug Administration ...

The U.S. Food and Drug Administration (FDA) has approved Abbott’s Tecnis Symfony Intraocular Lenses (IOL) for treating cataracts. According to Abbott, the Tecnis Symfony lenses are currently the only ...

IRVINE, Calif., Sept. 28, 2022 /PRNewswire/ -- Johnson & Johnson Vision,** a global leader in eye health and part of Johnson & Johnson MedTech,*** today announced availability of our ...

NEW ORLEANS — A new extended-range-of-vision intraocular lens fared well in terms of visual acuity in a prospective, bilateral, randomized, patient- and investigator-masked trial conducted at 15 sites ...

Abbott has earned FDA approval for its Tecnis Symfony Intraocular Lenses for the treatment of cataracts. The approval includes the Tecnis Symfony Toric IOL, a version of the lenses that are made for ...